<< >>

ID	Publikation
21185	Adam, I., Dewi, D.L., Mooiweer, J., Sadik, A., Mohapatra, S.R., Berdel, B., Keil, M., Sonner, J.K., Thedieck, K., Rose, A.J., Platten, M., Heiland, I., Trump, S., Opitz, C.A. (2018): Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation Oncoimmunology 7 (12), e1486353 Volltext (DOI)
18223	Dewi, D.L., Mohapatra, S.R., Cabañes, S.B., Adam, I., Patterson, L.F.S., Berdel, B., Kahloon, M., Thürmann, L., Loth, S., Heilmann, K., Weichenhan, D., Mücke, O., Heiland, I., Wimberger, P., Kuhlmann, J.D., Kellner, K.-H., Schott, S., Plass, C., Platten, M., Gerhäuser, C., Trump, S., Opitz, C.A. (2017): Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer Oncoimmunology 6 (2), e1274477 Volltext (DOI)
18890	Dewi, D.L., Mohapatra, S., Wimberger, P., Kuhlmann, J.D., Schott, S., Kellner, K.-H., Gerhauser, C., Trump, S., Opitz, C.A. (2017): Epigenetic regulation of indoleamine-2,3-dioxygenase 1 expression in human breast cancer Breast 32 (Suppl. 1), S31 - S32 Volltext (DOI)
14754	Litzenburger, U.M., Opitz, C.A., Sahm, F., Rauschenbach, K.J., Trump, S., Winter, M., Ott, M., Ochs, K., Lutz, C., Liu, X., Anastasov, N., Lehmann, I., Höfer, T., von Deimling, A., Wick, W., Platten, M. (2014): Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR Oncotarget 5 (4), 1038 - 1051 Volltext (DOI)
11625	Opitz, C.A., Litzenburger, U.M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., Jugold, M., Guillemin, G.J., Miller, C.L., Lutz, C., Radlwimmer, B., Lehmann, I., von Deimling, A., Wick, W., Platten, M. (2011): An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor Nature 478 (7368), 197 - 203 Volltext (DOI)
23546	Sadik, A., Somarribas Patterson, L.F., Öztürk, S., Mohapatra, S.R., Panitz, V., Secker, P.F., Pfänder, P., Loth, S., Salem, H., Prentzell, M.T., Berdel, B., Iskar, M., Faessler, E., Reuter, F., Kirst, I., Kalter, V., Foerster, K.I., Jäger, E., Ramallo Guevara, C., Sobeh, M., Hielscher, T., Poschet, G., Reinhardt, A., Hassel, J.C., Zapatka, M., Hahn, U., von Deimling, A., Hopf, C., Schlichting, R., Escher, B.I., Burhenne, J., Haefeli, W.E., Ishaque, N., Böhme, A., Schäuble, S., Thedieck, K., Trump, S., Seiffert, M., Opitz, C.A. (2020): IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression Cell 182 (5), 1252 - 1270.e34 Volltext (DOI)

<< >>